James Engles
About
In The Last Decade
James Engles
23 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 989
- Cancer Research 439
- Surgery 408
- Oncology 359
- Physiology 305
Countries citing papers authored by James Engles
This map shows the geographic impact of James Engles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Engles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Engles more than expected).
Fields of papers citing papers by James Engles
This network shows the impact of papers produced by James Engles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Engles. The network helps show where James Engles may publish in the future.
Co-authorship network of co-authors of James Engles
This figure shows the co-authorship network connecting the top 25 collaborators of James Engles. A scholar is included among the top collaborators of James Engles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Engles. James Engles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 54 | |
| 3 | 35 | |
| 4 | 159 | |
| 5 | 204 | |
| 6 | 14 | |
| 7 | 127 | |
| 8 | 21 | |
| 9 | 30 | |
| 10 | 30 | |
| 11 | 43 | |
| 12 | 52 | |
| 13 | 0 | |
| 14 | 37 | |
| 15 | Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. | 43 |
| 16 | Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy. | 42 |
| 17 | Intense (18)F-FDG uptake in brown fat can be reduced pharmacologically. | 118 |
| 18 | Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. | 495 |
| 19 | 94 | |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.